Brazil wants to buy Pharma tech from the Ukraine

- Last updated on GMT

Related tags: São paulo, Brazil

Brazil plans pharma investment in the Ukraine
Brazil wants to buy pharmaceutical manufacturing technology from the Ukraine as part of a $4.5bn investment plan.

News of the deal emerged earlier this week, just one month after Ukrainian officials visited Sao Paulo as part of a 15 country ‘roadshow’ designed to attract investment.

At the time José Barouki, director of trade and investment company Daruvar SA, said: "We want to build the mini-tractors production plant in Ukraine as well as purchase shipbuilding and pharmaceutical manufacturing technology​.”

The deal – terms of which have not been disclosed – builds on a number of existing agreements between Brazilian and Ukrainian firms.

In May, Brazilian state pharmaceutical group Farmanguinhos/Fiocruz bought 3.5 million vials of genetically engineered human insulin from Ukrainian insulin producer Indar. The countries also have also signed a preliminary agreement to establish bilateral insulin production in Brazil using Ukrainian technology by 2014.

Related news

Show more

Related products

show more

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Shifting the Biomanufacturing Paradigm

Shifting the Biomanufacturing Paradigm

BioContinuum™ Platform - MilliporeSigma | 01-Jul-2020 | Technical / White Paper

Adoption of next generation processing and technologies can enable improvements in productivity by streamlining workflows, reducing the manufacturing plant...

Related suppliers

Follow us

Products

View more

Webinars